Surgery Partners (SGRY) Releases Q3 2026 Earnings: Revenue Misses and Net Loss Widens

Surgery Partners, Inc. ($SGRY) reported third-quarter 2026 revenue of $815.3 million, slightly below the prior year and under Wall Street expectations of about $842.2 million. Gross profit fell to $185.0 million, while operating profit declined to $85.6 million, reflecting softer profitability in the quarter.

The company posted a net loss attributable to common shareholders of $21.1 million, or -$0.16 per diluted share, compared with a smaller loss a year earlier. Cost of sales rose to $630.3 million, weighing on margins and contributing to the weaker bottom line.

On the positive side, cash generation improved. Cash from operating activities climbed to $103.5 million, and cash and cash equivalents rose to $354.5 million. Total liabilities also declined to $3.79 billion, suggesting a stronger balance sheet position even as earnings remained under pressure.

• Revenue: $815.3 million
• Operating profit: $85.6 million
• Net loss: $21.1 million
• Operating cash flow: $103.5 million
• Cash and equivalents: $354.5 million

Note: This financials data is sourced from a third-party provider and has not been independently verified by Investivoq.

Surgery Partners, Inc. Insider Trading Activity

Surgery Partners, Inc. insiders have traded $SGRY stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SGRY stock by insiders over the last 6 months:

• TERESA DELUCA purchased 10,000 shares for an estimated $143,500

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

Surgery Partners, Inc. Hedge Fund Activity

We have seen 97 institutional investors add shares of Surgery Partners, Inc. stock to their portfolio, and 89 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 5,900,860 shares (+38474.7%) to their portfolio in Q2 2026, for an estimated $99,134,448
• KING STREET CAPITAL MANAGEMENT, L.P. removed 4,171,589 shares (-40.8%) from their portfolio in Q2 2026, for an estimated $70,082,695
• GLENVIEW CAPITAL MANAGEMENT, LLC removed 1,800,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $30,240,000
• PENTWATER CAPITAL MANAGEMENT LP added 1,630,000 shares (+16.3%) to their portfolio in Q2 2026, for an estimated $27,384,000
• UBS GROUP AG removed 1,618,368 shares (-15.9%) from their portfolio in Q2 2026, for an estimated $27,188,582
• SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,081,600 shares (+inf%) to their portfolio in Q2 2026, for an estimated $18,170,880
• HEIN PARK CAPITAL MANAGEMENT LP added 1,068,621 shares (+inf%) to their portfolio in Q2 2026, for an estimated $17,952,832

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.